MK0767
Sponsors
Merck Sharp & Dohme LLC
Conditions
Diabetes MellitusDiabetes Mellitus, Type 2Diabetes Mellitus, Type IIDyslipidemiaMetabolic X Syndrome DyslipidemiaType 2 Diabetes Mellitus
Phase 2
Phase 3
MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)
TerminatedNCT00543010
Start: 2002-11-30End: 2003-11-30Updated: 2015-06-12
MK0767 and Metformin Combination Study (0767-028)
TerminatedNCT00543738
Start: 2003-06-30End: 2003-12-31Updated: 2015-06-17
MK0767 and Sulfonylurea Combination Study (0767-027)
TerminatedNCT00543491
Start: 2003-05-31End: 2003-12-31Updated: 2015-06-12
Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)
TerminatedNCT00543361
Start: 2003-05-31End: 2003-12-31Updated: 2015-06-12
Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)
TerminatedNCT00543751
Start: 2003-01-31End: 2003-11-30Updated: 2015-06-17
MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)
TerminatedNCT00543816
Start: 2003-08-31End: 2003-11-30Updated: 2015-06-23
Study A - MK0767 Monotherapy Study
TerminatedNCT00543517
Start: 2003-02-28End: 2003-11-30Updated: 2015-02-10
Dyslipidemia in Type 2 Diabetes (0767-034)
TerminatedNCT00547274
Start: 2003-07-31End: 2003-11-30Updated: 2015-06-12